Ipamorelin 10mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only – not for human or veterinary use.   Product Overview Ipamorelin is a selective growth-hormone releasing peptide (GHRP) widely examined in research for its relevance to GH-axis modulation, receptor-specific signalling and controlled pituitary activity. This lyophilized 10 mg peptide supports structured laboratory evaluation of purity identity and mechanistic behaviour.   Peptide Overview From 2012 to 2025 Ipamorelin gained substantial scientific interest for its GH-secretagogue profile, receptor selectivity and well-defined biochemical characteristics. Its stability and purity make it a suitable model for reproducible in-vitro studies evaluating short-acting GH-modulation.   Historical Background and Scientific Context GHRP-class compounds such as Ipamorelin became a major study focus between 2014 and 2025, particularly in research exploring pituitary response, GH-pulsatility and comparative activity versus related secretagogues. Its analytical consistency supports high-quality biochemical modelling.   Mechanistic Focus in Research

• GH-axis stimulation and receptor modelling
• In-vitro evaluation of pituitary response pathways
• Comparative analysis within GHRP-class peptides
• Biochemical profiling of secretagogue activity
• Controlled structure–function modelling experiments

  Analytical Verification (COA) Independent Liquilabs analysis confirms analytical validation for Batch GF082025023. Key results include:

• Assay Content: 9.99 mg
• Identification – Retention Time: 0.999
• Identification – Spectrum: 997
• Purity: above 99.8 percent
• Endotoxins: detected but below 0.01 EU per mg
• Microbial Growth: not detected for aerobic count yeast or mold
• Heavy Metals: not detected including arsenic cadmium cobalt lead nickel mercury vanadium

All analytical values were produced using validated chromatographic spectroscopic and microbiological procedures ensuring transparent traceability.   Research Applications

• GH-secretagogue pathway modelling
• Pituitary receptor-respo

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

• Verified and analysed with Liquilabs s.r.o. Czechia
• Above 99.8 percent purity with validated assay content
• Endotoxin detected but below 0.01 EU per mg
• No detectable heavy metals or microbial contamination
• Batch GF082025023 – Published September 2025
• EU shipments include bacteriostatic water
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.